The chemical landscape of pharmaceutical development is rich with compounds that, while not end-products themselves, are critical enablers of therapeutic breakthroughs. Among these is CAS 123855-55-0, known scientifically as 2-(Furfurylsulfinyl)acetic acid p-Nitrophenyl Ester. This molecule's unique chemical properties are central to its role as a precursor for histamine H2-receptor antagonists, a class of drugs vital in managing conditions like acid reflux and peptic ulcers. NINGBO INNO PHARMCHEM CO.,LTD. is actively involved in the supply of this compound, understanding that its specific reactivity and stability are key to successful drug synthesis.

The structure of CAS 123855-55-0, featuring a furan ring, a sulfinyl group, and a p-nitrophenyl ester, endows it with specific chemical behaviors that are leveraged in organic synthesis. Its utility as a Lafutidine intermediate product highlights its designed functionality within a complex synthesis route. For drug discovery programs, understanding these chemical properties allows researchers to predict reaction outcomes, optimize yields, and explore potential modifications for new therapeutic entities. NINGBO INNO PHARMCHEM CO.,LTD. contributes to this process by ensuring consistent quality and providing detailed specifications for this intermediate, thereby supporting the rigorous demands of pharmaceutical research and development.

The journey from intermediate to effective drug is intricate, and the characteristics of compounds like CAS 123855-55-0 are paramount. As a precursor for histamine H2-receptor antagonists, its precise chemical interactions during synthesis are crucial. NINGBO INNO PHARMCHEM CO.,LTD. recognizes the significance of supplying this compound with high assay values and consistent physical form. This diligence is essential for researchers and manufacturers who rely on these precise chemical properties to advance their drug discovery pipelines, ultimately aiming to bring safer and more effective treatments to patients. The company's role underscores the foundational importance of chemical intermediates in the innovation cycle of the pharmaceutical industry.